Healthcare sector news
European Medicines Agency doesn’t give regulatory approval to new osteoporosis drug
The European Medicines Agency (EMA) Committee for Medicinal Products for Human Use (CHMP) has adopted a negative opinion on the Marketing Authorisation Application for EVENITY® (romosozumab), a potential new osteoporosis drug.
We're reviewing our printed information
We’re reviewing our range of printed information and materials to ensure it meets the needs of you and your patients.
Why you should get certified in bone densitometry
Registration is open for our National Training Scheme for Bone Densitometry, starting this October. Sue Lowther, radiographer and previous student of the course, tells us about her experiences of the training scheme and how being certified in bone densitometry has benefitted her work.
Amgen launches new Competitive Grant Program in Bone Research
Amgen has launched a new Competitive Grant Program in Bone Research. This is a global, independently-reviewed competitive grant programme, offering individual grants of up to 150,000 USD for novel research proposals that seek to improve quality of osteoporosis care and patient outcomes.
New osteoporosis medication romosozumab approved in the US
The new osteoporosis medication romosozumab has been approved for use in the US by the Food and Drug Administration (FDA) this week.